Download only This guide explains how to use extended-release injectable naltrexone as part of medication-assisted treatment (MAT) for opioid use disorder. It covers assessing patients, initiating MAT, monitoring progress, and deciding when to end treatment. Publication ID SMA14-4892R Publication Date December 2014 Format Guidelines or Manual Download Naltrexone & Treatment of Opioid Use Disorder PDF 446.99 KB Find Related Information Audience Professional Care Providers Population Group People with Substance Use or Abuse Problems as Population Group You May Also Be Interested In Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use Disorder and Their Infants This Clinical Guide provides comprehensive, national guidance for optimal management of pregnant and parenting women with opioid use disorder and their infants. The Clinical Guide helps healthcare professionals and patients determine the most clinically appropriate action for a particular situation and informs individualized treatment decisions. Pharmacologic Guidelines for Treating Individuals with Post-Traumatic Stress Disorder and Co-Occurring Opioid Use Disorders This manual offers guidelines for medication-assisted treatment for people, particularly veterans, living with post-traumatic stress disorder and co-occurring opioid use disorders. It covers screening, concomitant treatment, pharmacotherapy, and multiple misused substances. Medication-Assisted Treatment of Opioid Use Disorder Pocket Guide This guide is for physicians using medication-assisted treatment for patients with opioid use disorder. It discusses various types of approved medications, screening and assessment tools, and best practices for patient care. Advisory: Sublingual and Transmucosal Buprenorphine for Opioid Use Disorder: Review and Update This advisory summarizes data on the use of sublingual and transmucosal buprenorphine for the medication-assisted treatment of opioid use disorder. A Collaborative Approach to the Treatment of Pregnant Women with Opioid Use Disorders This manual offers best practices to states, tribes, and local communities on collaborative treatment approaches for pregnant women living with opioid use disorders, and the risks and benefits associated with medication-assisted treatment. Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs This guide informs clinicians about medications for opioid use disorder treatment, including side effects, drug interactions, and take-home doses. It discusses patient counseling, associated medical issues, hepatitis C evaluation, drug testing, and pregnant women.